15 Sep Partner Spotlight: LLS Financial Assistance for PCR Testing
Today we are sharing some exciting news from our partner Leukemia and Lymphoma Society about a new financial assistance program!
The Leukemia and Lymphoma Society is pleased to announce the opening of the LLS PCR Testing Financial Assistance and Awareness Program for patients with chronic myeloid leukemia (CML).
Patients enrolled in this program may receive up to $1,000 of financiall assistance for out-of-pocket costs directly related to PCR testing during their enrollment period.
The Polymerase chain reaction (PCR) test is used both in the diagnosis of CML and to monitor for cancerous cells after treatment has begun. It is the most sensitive testing method available, with the ability to detect a single cancerous cell among one million healthy cells. Recommendations suggest that a CML patient should receive a PCR test every three months for the first three years after diagnosis, and every three to six months thereafter based on how well their treatment is working.
Acceptance into the program is first-come, first-served and is based on financial eligibility. A patient may be insured or uninsured. Support for this program is provided by Bristol-Myers Squibb.
For more information or to apply, please visit www.LLS.org/PCR or call (877) 614-9242.